ArticleNature immunology2024

The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.

Xin He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.